CINECA IRIS Institutional Research Information System

FERRANNINI, ELEUTERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.312
AS - Asia 20.787
EU - Europa 14.714
SA - Sud America 2.965
AF - Africa 440
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 17
Totale 80.298
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.010
CN - Cina 6.548
SG - Singapore 6.089
IT - Italia 4.847
HK - Hong Kong 3.713
BR - Brasile 2.569
SE - Svezia 2.314
BG - Bulgaria 1.705
UA - Ucraina 1.139
TR - Turchia 1.132
DE - Germania 1.101
CA - Canada 1.068
KR - Corea 1.028
VN - Vietnam 941
GB - Regno Unito 877
FI - Finlandia 814
RU - Federazione Russa 739
CH - Svizzera 477
IN - India 316
BD - Bangladesh 200
FR - Francia 186
IQ - Iraq 131
AR - Argentina 125
JP - Giappone 121
MX - Messico 101
AT - Austria 99
BE - Belgio 82
CI - Costa d'Avorio 81
PK - Pakistan 78
SA - Arabia Saudita 76
MA - Marocco 61
UZ - Uzbekistan 61
ZA - Sudafrica 61
EC - Ecuador 60
NL - Olanda 59
VE - Venezuela 58
PL - Polonia 57
SN - Senegal 55
ID - Indonesia 49
AU - Australia 48
CO - Colombia 48
ES - Italia 45
KE - Kenya 35
EG - Egitto 32
GR - Grecia 32
NP - Nepal 31
IE - Irlanda 30
IL - Israele 30
JO - Giordania 30
AE - Emirati Arabi Uniti 27
PY - Paraguay 27
UY - Uruguay 27
JM - Giamaica 25
TN - Tunisia 23
PE - Perù 22
BJ - Benin 21
CL - Cile 21
TT - Trinidad e Tobago 18
CZ - Repubblica Ceca 17
DZ - Algeria 17
KZ - Kazakistan 17
OM - Oman 17
RO - Romania 16
EU - Europa 14
LT - Lituania 14
AL - Albania 13
AZ - Azerbaigian 13
PH - Filippine 13
MY - Malesia 12
NZ - Nuova Zelanda 12
PA - Panama 12
CR - Costa Rica 11
ET - Etiopia 11
BH - Bahrain 10
DO - Repubblica Dominicana 10
HU - Ungheria 10
NG - Nigeria 10
PS - Palestinian Territory 10
KW - Kuwait 9
LB - Libano 9
TH - Thailandia 9
TW - Taiwan 9
HN - Honduras 8
PT - Portogallo 8
BS - Bahamas 7
DK - Danimarca 7
GE - Georgia 7
IR - Iran 7
RS - Serbia 7
AM - Armenia 6
BB - Barbados 6
BN - Brunei Darussalam 6
BO - Bolivia 6
GA - Gabon 6
GT - Guatemala 6
MN - Mongolia 6
SV - El Salvador 6
AO - Angola 5
BZ - Belize 5
KG - Kirghizistan 5
Totale 80.209
Salva come PNG Salva come JPEG
Città #
Fairfield 4.810
Ashburn 4.401
Hong Kong 3.680
Woodbridge 3.443
Singapore 3.261
Chandler 2.573
Ann Arbor 2.315
Houston 2.271
Milan 2.070
Seattle 1.937
Sofia 1.702
Cambridge 1.592
Wilmington 1.591
Jacksonville 1.516
Santa Clara 1.516
Dallas 1.470
Hefei 1.291
Shanghai 1.243
Beijing 1.202
Seoul 1.007
Ottawa 956
New York 941
Izmir 756
Boardman 730
Serra 693
Princeton 687
Lawrence 636
Nanjing 616
Medford 607
Los Angeles 491
Bern 461
Des Moines 424
Buffalo 295
Istanbul 275
Dearborn 264
Jüchen 257
Nanchang 253
San Diego 228
Dong Ket 222
São Paulo 216
Redondo Beach 177
Falls Church 170
The Dalles 168
Rome 158
Munich 157
Columbus 156
Kunming 151
Shenyang 129
San Jose 127
London 122
Hebei 114
Boulder 113
Ho Chi Minh City 111
Council Bluffs 102
Tokyo 98
Tianjin 97
Chicago 93
Redwood City 92
Ogden 91
Changsha 90
Jiaxing 83
Helsinki 82
Abidjan 81
Florence 78
Brussels 75
Rio de Janeiro 75
Norwalk 72
Frankfurt am Main 71
Lancaster 69
Pisa 69
Washington 69
Vienna 68
Hanoi 65
Belo Horizonte 62
Dhaka 62
Hangzhou 56
Pune 56
Tashkent 56
Dakar 54
Baghdad 49
Orange 48
Brasília 46
Curitiba 46
Guangzhou 46
Nuremberg 45
Warsaw 44
Zhengzhou 40
Auburn Hills 39
Jinan 38
San Francisco 37
Verona 36
Düsseldorf 35
Porto Alegre 35
Changchun 33
Lanzhou 31
Ningbo 30
Campinas 29
Indiana 29
Nairobi 29
Casablanca 28
Totale 59.511
Salva come PNG Salva come JPEG
Nome #
Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus 310
F-18-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: A validation study 243
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 241
[C-11]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia 239
Quantification of liver glucose metabolism by positron emission tomography: Validation study in pigs 227
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 216
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 215
EFFECT OF FATTY-ACIDS ON GLUCOSE-PRODUCTION AND UTILIZATION IN MAN 212
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. 209
Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest 209
THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW 206
LACK OF EFFECT OF PARATHYROID-HORMONE ON HEPATIC GLUCOSE-METABOLISM IN THE DOG 201
SPLANCHNIC AMINO-ACID AND GLUCOSE-METABOLISM DURING AMINO-ACID INFUSION IN DOGS 201
RESPONSE TO INTRAVENOUS GLUCOSE OF PATIENTS ON MAINTENANCE HEMODIALYSIS - EFFECTS OF DIALYSIS 199
INSULIN RESISTANCE, INSULIN DEFICIENCY AND THE PATHOGENESIS OF DIABETES-MELLITUS 198
PATTERN OF INSULIN DELIVERY AFTER INTRAVENOUS GLUCOSE INJECTION IN MAN AND ITS RELATION TO PLASMA-GLUCOSE DISAPPEARANCE 197
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects 196
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 195
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 194
ADRENERGIC-BLOCKADE ALTERS GLUCOSE KINETICS DURING EXERCISE IN INSULIN-DEPENDENT DIABETICS 193
PARENTAL HISTORY OF DIABETES IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK-FACTORS 193
Effect of 1-year treatment with interferon-beta 1b on thyroid function and autoimmunity in patients with multiple sclerosis 193
ACUTE RESPIRATORY-DISTRESS SYNDROME IN AN ADULT PATIENT WITH A MYELODYSPLASTIC DISORDER 192
REGULATION OF SPLANCHNIC AND PERIPHERAL GLUCOSE-UPTAKE BY INSULIN AND HYPERGLYCEMIA IN MAN 192
INSULIN ACTION AND SUBSTRATE COMPETITION 192
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 191
MECHANISM OF IMPROVEMENT IN GLUCOSE-METABOLISM AFTER CHRONIC GLYBURIDE THERAPY 188
Skin Vasodilator Function and Vasomotion in Patients with Morbid Obesity: Effects of Gastric Bypass Surgery 188
Adipocyte P2X(7) receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome? 188
THE DISPOSAL OF AN ORAL GLUCOSE-LOAD IN HEALTHY-SUBJECTS - A QUANTITATIVE STUDY 187
A MODEL OF GLUCOSE KINETICS AND THEIR CONTROL BY INSULIN, COMPARTMENTAL AND NONCOMPARTMENTAL APPROACHES 186
HEPATIC AND PERIPHERAL INSULIN RESISTANCE - A COMMON FEATURE OF TYPE-2 (NON-INSULIN-DEPENDENT) AND TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS 185
THE PATHOGENESIS OF NON-INSULIN-DEPENDENT DIABETES 185
OPERATION OF RANDLES CYCLE IN PATIENTS WITH NIDDM 185
DIFFERENTIAL-EFFECTS OF INSULIN AND HYPERGLYCEMIA ON INTRACELLULAR GLUCOSE DISPOSITION IN HUMANS 185
Thiazolidinediones improve beta-cell function in type 2 diabetic patients 185
Physical activity and insulin sensitivity - the RISC Study 185
TRANSIENT HEPATIC RESPONSE TO GLUCAGON IN MAN - ROLE OF INSULIN AND HYPERGLYCEMIA 183
SODIUM ELEVATES THE PLASMA-GLUCOSE RESPONSE TO GLUCOSE-INGESTION IN MAN 183
ACUTE ELEVATION OF FREE FATTY-ACID LEVELS LEADS TO HEPATIC INSULIN RESISTANCE IN OBESE SUBJECTS 183
Effects of insulin on the kidney and the cardiovascular system 183
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 182
IMPAIRED INSULIN DEGRADATION IN A PATIENT WITH INSULIN RESISTANCE AND ACANTHOSIS NIGRICANS 181
HEPATIC AND EXTRAHEPATIC SPLANCHNIC GLUCOSE-METABOLISM IN THE POSTABSORPTIVE AND GLUCOSE FED DOG 180
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery 180
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance 179
EFFECT OF INSULIN AND GLUCOSE ON FEEDING-BEHAVIOR 178
INTERNAL BILIARY DIVERSION IMPROVES GLUCOSE-TOLERANCE IN THE RAT 177
Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. 177
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline 176
INFLUENCE OF LONG-TERM DIABETES ON LIVER-GLYCOGEN METABOLISM IN THE RAT 175
Sibutramine lost and found 175
Adiponectin and left ventricular structure and function in healthy adults 175
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. 175
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects 174
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 174
Differential effect of weight loss on insulin resistance in surgically treated obese patients 174
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T-4 replacement therapy 173
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis 172
METABOLIC EFFECTS OF LOW-DOSE INSULIN THERAPY ON GLUCOSE-METABOLISM IN DIABETIC-KETOACIDOSIS 171
Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. 171
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 171
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects 169
Insulin: new roles for an ancient hormone 169
RELATION OF BIRTH-WEIGHT TO MATERNAL PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS DURING NORMAL-PREGNANCY 168
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 168
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 168
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 166
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 166
TIME-DEPENDENCE OF THE INTERACTION BETWEEN LIPID AND GLUCOSE IN HUMANS 165
Beta-cell function in obesity: effects of weight loss 165
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control 164
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function 164
METABOLIC BASIS OF OBESITY AND NONINSULIN-DEPENDENT DIABETES-MELLITUS 163
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation 163
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects 163
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. 163
POSTPERICARDIECTOMY SYNDROME IN A PATIENT WITH RADIATION-INDUCED PERICARDIAL-EFFUSION 162
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 162
Effect of acute hyperglycemia on insulin secretion in humans 162
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells 161
Hypertension, insulin resistance, and diabetes 160
Endothelial dysfunction in type 2 diabetes 160
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism 160
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 160
INSULIN KINETICS AND GLUCOSE-INDUCED INSULIN DELIVERY IN CHRONICALLY DIALYZED SUBJECTS - ACUTE EFFECTS OF DIALYSIS 159
SYNERGISTIC INTERACTION BETWEEN EXERCISE AND INSULIN ON PERIPHERAL GLUCOSE-UPTAKE 159
The effect of rosiglitazone on the liver: Decreased gluconeogenesis in patients with type 2 diabetes 159
Fasting-based estimates of insulin sensitivity in overweight and obesity: A critical appraisal 159
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 159
EFFECTS OF PHYSIOLOGICAL PLASMA-INSULIN LEVELS ON GLUCOSE-TURNOVER PARAMETERS IN FAMILIAL HYPERCHOLESTEROLEMIA 158
INFLUENCE OF PLASMA-GLUCOSE AND INSULIN CONCENTRATION ON PLASMA-GLUCOSE CLEARANCE IN MAN 157
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes 157
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 157
THYROID AUTOIMMUNITY AND DYSFUNCTION ASSOCIATED WITH TYPE I INTERFERON THERAPY 156
THE RELATIONSHIP OF PLASMA CATECHOLAMINE AND LACTATE DURING ANAEROBIC THRESHOLD EXERCISE IN MITOCHONDRIAL MYOPATHIES 156
INSULIN KINETICS AFTER PORTAL AND PERIPHERAL INJECTION OF [INSULIN[I-125] .1. DATA-ANALYSIS AND MODELING 155
HEPATIC GLUCOSE-PRODUCTION IN INSULIN-RESISTANT STATES 155
INSULIN-RESISTANCE AND INSULIN DEFICIENCY IN THE PATHOGENESIS OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - ERRORS OF METABOLISM OR OF METHODS 155
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients 155
Totale 18.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 229.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 229.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.957 0 0 0 0 0 0 340 607 370 538 271 831
2021/20226.921 99 372 166 482 1.405 1.004 138 354 396 210 314 1.981
2022/20236.532 923 645 328 631 867 1.014 59 513 1.054 56 372 70
2023/20246.556 1.153 887 902 486 1.025 1.011 49 234 121 71 75 542
2024/202517.384 48 728 78 862 1.242 1.689 1.363 1.183 1.819 2.455 2.133 3.784
2025/202611.114 1.687 2.884 2.092 1.117 1.290 2.003 41 0 0 0 0 0
Totale 81.003